Patients around the world face stark inequalities in access to cancer treatment, according to a report published today (Thursday 10 May) in the cancer journal, Annals of Oncology. The report’s authors urge decision makers in every country to take action and ensure that everyone has equal access to new cancer drugs when they are needed, wherever they live.
Hamilton College researchers have identified molecules that have been shown to be effective in the fight against breast cancer.
The customary ethical norms of the doctor-patient relationship, such as patient autonomy and confidentiality, are often challenged when the doctor is a team physician and the patient is an athlete.
Rotator cuff surgery typically leads to decreased shoulder pain and improved function.
New-onset sarcoidosis of the lung is on the rise among Ground Zero firefighters, according to a new study.
A new study supports earlier estimates of the prevalence of bipolar disorder in the US population, and suggests the illness may be more accurately characterized as a spectrum disorder. It also finds that many people with the illness are not receiving appropriate treatment.
When emergency teams are well informed and governments can coordinate their efforts, lives and property can be saved. The Health Early Warning System, a project supported by ESA, is intended to bring this benefit to Europe.
Breathing air containing coarse particulate matter such as road or construction dust may cause heart problems for asthma sufferers and other vulnerable populations, according to a new study led by the University of North Carolina at Chapel Hill School of Public Health.
A clinical trial treating the papillomaviruses responsible for genital warts was on target at the halfway mark, according to Australian of the Year 2006 Professor Ian Frazer and trial manager, sexual health specialist Dr David Jardine.
The off-label and untested use of drug-coated stents in the treatment of coronary artery blockage is common in US practice, and ischemic complication rates are higher among patients receiving drug-coated stents for off-label indications, according to two studies in the May 9 issue of JAMA.